DE Frankfurt Schmoll D: Difference between revisions

From Bioblast
No edit summary
No edit summary
Β 
(7 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{MiPNetLab
{{O2k-Network Lab
|institution=Sanofi-Aventis Deutschland GmbH
|institution=Sanofi-Aventis Deutschland GmbH


Line 9: Line 9:
|city=Frankfurt
|city=Frankfurt
|country=Germany
|country=Germany
|Contact=Schmoll D
|Contact=Schmoll Dieter
|MiPNetLab=Fischer S, Schlotte V
|MiPNetLab=Fischer Silvia
|Status=O2k 2009-
|Status=O2k 2009-
|keywords=
|info=[[IOC88]], [[IOC75]], [[IOC60]], [[IOC54]]
}}
}}
== Power-O2k ==
== Power-O2k ==
* [[DE Frankfurt Sanofi]]
::::* [[DE Frankfurt Sanofi]]

Latest revision as of 15:36, 21 March 2019

                



DE Frankfurt Schmoll D

Oroboros O2k-Network

O2k-Network
O2k-Network Lab Sanofi-Aventis Deutschland GmbH

R&D TD Metabolism FFM

Address Industriepark Hoechst

Bldg. H825, Room 243, 65926

City Frankfurt
State/Prov
Country Germany
Weblink
Contact Schmoll Dieter
Team Fischer Silvia
Team previous
Status O2k 2009-
Oroboros Events IOC88, IOC75, IOC60, IOC54
Topics


O2k-Publications

 PublishedReference
Karusheva 2019 Am J Clin Nutr2019Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, BΓ³dis K, BΓ€renz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, MΓΌssig K, Szendroedi J, Roden M (2019) Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr 110:1098-107.

O2k-Abstracts

update please

Power-O2k

Cookies help us deliver our services. By using our services, you agree to our use of cookies.